Brett Monia | Founder, CEO & Director |
Elizabeth Hougen | EVP, Finance & CFO |
Eugene Schneider | EVP & Chief Clinical Development Officer |
Eric Swayze | EVP, Research |
Onaiza Cadoret | EVP and Chief Product Strategy & Operations Officer |
Yanan Zhu | Wells Fargo Securities |
Brendan Smith | Cowen and Company |
Luca Issi | RBC Capital Markets |
Jessica Fye | JPMorgan Chase & Co. |
Mani Foroohar | SVB Leerink |
Gary Nachman | BMO Capital Markets |
I-Eh Jen | Laidlaw & Company |
Myles Minter | William Blair & Company |
Joseph Stringer | Needham & Company |
Alexander Thompson | Stifel, Nicolaus & Company |
Good morning, and welcome to the Ionis Pharmaceuticals First Quarter 2022 Financial Results Conference Call.
As a reminder, this call is being recorded. At this time, I would like to turn the call over to Ms. Julie Tepper, Investor Relations, to lead off the call. Please begin, ma'am.